<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">As of April 12, 2020, the Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome (SARS)–CoV-2 virus has affected more than 550,000 Americans, and claimed more than 21,000 lives.
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> In just 2 months, the number of deaths is projected to reach over 60,000 — despite current levels of social distancing and other preventive measures.
 <xref rid="bib3" ref-type="bibr">
  <sup>3</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref> Health care workers are placing their lives at risk, and are facing enormous physical and emotional stress. The shortage of testing, masks, other personal protective equipment, and ventilators threatens to make our predicament worse. But unfortunately, we are already in the midst of another devastating problem: the shortage of medications that are critical for the management of COVID-19.
</p>
